Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Remus Pharmaceuticals Ltd

NSE: REMUS · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹946.00
Market cap: ₹1,115 Cr
Revenue (annual): ₹853.6 Cr
Net profit (annual): ₹36.99 Cr
P/E (TTM): 30.1×Sector 50.4×
Promoter holding: 70.95%
FII holding: 5.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 SME to Main Board Migration 1 Merger & Restructuring 1 Management Change 1 Financial Results 1 Dividend 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

20 May 2026 15:15 IST NSE

Financial Results

Remus Pharmaceuticals H2 FY26 Results: Net Profit ₹24.6 Cr, Up 19.4% YoY

Remus Pharmaceuticals Ltd reported revenue from operations of ₹453.4 Cr (+30.4% YoY) and net profit of ₹24.6 Cr (+19.4% YoY) for H2 FY26.

Key figure: Net profit ₹24.6 Cr · +19.4% YoY

Open full results → Read the filing ↗